A GLP-1 pill wouldnt need sophisticated cold-chain distribution and storage, meaning it could be sold in countries that dont have that infrastructure
This past fall, Sophia became the first pediatric patient in the Cleveland area to be treated with this novel therapy
[1] [2] This medication works by mimicking the action of the naturally occurring hormone GLP-1, which stimulates insulin secretion in a glucose-dependent manner, suppresses glucagon release, slows gastric emptying, and reduces appetite through central nervous system pathways
When a GLP-1 reset is NOT the answer Not every stall needs a reset
Volpe, S., Lisco, G., Racaniello, D., Fanelli, M., Colaianni, V., Vozza, A., Triggiani, V., Sabb, C., Tortorella, C., De Pergola, G., & Piazzolla, G
10.1016/j.intimp.2024.113537 [DOI] [PubMed] [Google Scholar] Singh A., Sohal A., Batta A